{"DataElement":{"publicId":"5401011","version":"1","preferredName":"Derkay Recurrent Papillomatosis Assessment Total Score","preferredDefinition":"Numeric value representing the sum of scores from all anatomic sites assessed for recurrent papillomatosis using the Derkay staging measure.","longName":"DERKAY_PAP_TL_SC","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"5400982","version":"1","preferredName":"Derkay Staging System Papillomatosis Assessment Result","preferredDefinition":"A staging system for assessment of recurrent respiratory papillomatosis (RRP). The staging system includes a functional assessment of severity as well as an anatomic assessment of disease distribution. The anatomic score can then be used in combination with the functional assessment to measure an individual patient's clinical course and response to therapy over time._Glandular or squamous cell neoplastic proliferations characterized by the formation of multiple papillary structures diffusely involving a specific anatomic site._The result of an action._The final result of a determination of the value, significance, or extent of.","longName":"5525613v1.0:2972008v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"5525613","version":"1","preferredName":"Derkay Staging System Papillomatosis","preferredDefinition":"A staging system for assessment of recurrent respiratory papillomatosis (RRP). The staging system includes a functional assessment of severity as well as an anatomic assessment of disease distribution. The anatomic score can then be used in combination with the functional assessment to measure an individual patient's clinical course and response to therapy over time.:Glandular or squamous cell neoplastic proliferations characterized by the formation of multiple papillary structures diffusely involving a specific anatomic site.","longName":"C128932:C3713","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Derkay Staging System","conceptCode":"C128932","definition":"A staging system for assessment of recurrent respiratory papillomatosis (RRP). The staging system includes a functional assessment of severity as well as an anatomic assessment of disease distribution. The anatomic score can then be used in combination with the functional assessment to measure an individual patient's clinical course and response to therapy over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Papillomatosis","conceptCode":"C3713","definition":"Glandular or squamous cell neoplastic proliferations characterized by the formation of multiple papillary structures diffusely involving a specific anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F255E7F-5867-1740-E053-F662850A19D7","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"ONEDATA","dateModified":"2016-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2972008","version":"1","preferredName":"Assessment Outcome","preferredDefinition":"Having determined the value, significance, or extent of.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C25217:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BBF3488-2DC8-46D6-E040-BB89AD4326A8","latestVersionIndicator":"Yes","beginDate":"2009-12-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-27","modifiedBy":"ONEDATA","dateModified":"2009-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"39D1E883-A9A7-926B-E050-BB89AD43402E","latestVersionIndicator":"Yes","beginDate":"2016-08-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-08-11","modifiedBy":"SBR","dateModified":"2016-10-18","changeDescription":"Curated to support NCI CCR clinical trial.8.11.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3727197","version":"1","preferredName":"Total Score","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"3727197v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"3","minValue":"0","maxValue":"200","decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2495121","version":"1","preferredName":"Total Score","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25304:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"18650CB0-AACE-2241-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-12","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-12","modifiedBy":"ONEDATA","dateModified":"2006-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA6E1ED5-0056-6491-E040-BB89AD436A28","latestVersionIndicator":"Yes","beginDate":"2013-04-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-15","modifiedBy":"COOPERM","dateModified":"2016-01-21","changeDescription":"Created for use with C3D FACT questionnaire. mc 4/15/13 Release per approval by D.Reeves. mc 4/17/13 Classified for use with FACIT or FACT measures. mc 1/21/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Total Score all Sites","type":"Preferred Question Text","description":"Total Score all Sites","url":null,"context":"CCR"}],"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"39D208B1-4661-EBF6-E050-BB89AD4358B1","latestVersionIndicator":"Yes","beginDate":"2016-08-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-08-11","modifiedBy":"REEVESD","dateModified":"2016-10-18","changeDescription":"Curated to support NCI CCR clinical trial.8.11.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}